期刊
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
卷 45, 期 6, 页码 796-803出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.yjmcc.2008.09.124
关键词
Cardiac hypertrophy; PICOT; Contractility; Calcineurin; NFAT
资金
- Korean Ministry of Science and Technology [M6-0605-00-0001]
- NIH [HL-080498-01]
- Korean Systems Biology Research [M10503010001-07N0301-00110]
PICOT (PKC-interacting cousin of thioredoxin) was previously shown to inhibit the development of cardiac hypertrophy, concomitant with an increase in cardiomyocyte contractility. To explore the physiological function of PICOT in the hearts, we generated a PICOT-deficient mouse line by using a gene trap approach. PICOT-/- mice were embryonic lethal indicating that PICOT plays an essential role during embryogenesis, whereas PICOT+/- mice were viable with no apparent morphological defects. The PICOT protein levels were reduced by about 50% in the hearts of PICOT+/- mice. Significantly exacerbated cardiac hypertrophy was induced by pressure overload in PICOT+/- mice relative to that seen in wild type littermates. In line with this observation, calcineurin-NFAT signaling was greatly enhanced by pressure overload in the hearts of PICOT+/- mice. Cardiomyocytes from PICOT+/- mice exhibited significantly reduced contractility, which may be due in part to hypophosphorylation of phospholamban and reduced SERCA activity. These data indicate that the precise PICOT protein level significantly affects the process of cardiac hypertrophy and cardiomyocyte contractility. We suggest that PICOT plays as a critical negative regulator of cardiac hypertrophy and a positive inotropic regulator. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据